Effect of insulin-like growth factor gene polymorphisms alone or in interaction with diabetes on the risk of pancreatic cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 12, 2008, Pages 3467-3473

  Suzuki, Hideo ^a   Li, Yanan ^a   Dong, Xiaoqun ^a   Hassan, Manal M ^a   Abbruzzese, James L ^a   Li, Donghui ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN C;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; AGED; ALLELES; CASE-CONTROL STUDIES; DIABETES MELLITUS; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MODELS, STATISTICAL; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 57449120903     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0514     Document Type: Article

References (48)

1. American Cancer Society. Cancer figures and facts. Atlanta (GA): American Cancer Society; 2007.
2. Anderson K, Potter JD, Mack TM. Pancreatic cancer. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer epidemiology and prevention. New York (NY): Oxford University Press; 2006. p. 725-71.
3. Duell EJ, Holly EA, Bracci PM, et al. A population-based, case-control study of polymorphisms in carcinogen-metabolizing genes, smoking, and pancreatic adenocarcinoma risk. J Natl Cancer Inst 2002;94:297-306.
4. Li D, Jiao L, Li Y, et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 2006;27:103-11.
5. 399Gln polymorphism in X-ray repair cross- complementing group 1 [XRCC1] and risk of pancreatic adenocarcinoma. Cancer Res 2002;62:4630-6.
6. Jiao L, Hassan MM, Bondy ML, et al. XRCC2 and XRCC3 Gene polymorphism and risk of pancreatic cancer. Am J Gastroenterol 2008;103:360-7.
7. McWilliams RC, Bamlet WR, Cunningham JM, et al. Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 2008;68:4928-35.
8. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004;363:1346-53.
9. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
10. Werner H, Le Roith D. New concepts in regulation and function of the insulin-like growth factors: implications for understanding normal growth and neoplasia. Cell Mol Life Sci 2000;57:932-42.
11. Bergmann U, Funatomi H, Yokoyama M, Beger HG, Korc M. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995;55:2007-11.
12. Ohmura E, Okada M, Onoda N, et al. Insulin-like growth factor I and transforming growth factor a as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 1990;50:103-7.
13. Zeng H, Datta K, Neid M, Li J, Parangi S, Mukhopadhyay D. Requirement of different signaling pathways mediated by insulin-like growth factor-I receptor for proliferation, invasion, and VPF/VEGF expression in a pancreatic carcinoma cell line. Biochem Biophys Res Commun 2003;302:46-55.
14. Stoeltzing O, Liu W, Reinmuth N, et al. Regulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. Am J Pathol 2003;163:1001-11.
15. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5.
16. Nordqvist AC, Mathiesen T. Expression of IGF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002;57:19-26.
17. Sakatani T, Kaneda A, Iacobuzio-Donahue CA, et al. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science 2005;307:1976-8.
18. Cheng I, Stram DO, Penney KL, et al. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J Natl Cancer Inst 2006;98:123-34.
19. Ma J, Pollak MN, Giovannucci E, et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999;91:620-5.
20. Wong HL, Delellis K, Probst-Hensch N, et al. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in Singapore Chinese. Cancer Epidemiol Biomarkers Prev 2005;14:144-51.
21. Canzian F, McKay JD, Cleveland RJ, et al. Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 2006;94:299-307.
22. Al-Zahrani A, Sandhu MS, Luben RN, et al. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 2006;15:1-10.
23. Missmer SA, Haiman CA, Hunter DJ, et al. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 2002;100:332-6.
24. Hernandez W, Grenade C, Santos ER, Bonilla C, Ahaghotu C, Kittles RA. IGF1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African-Americans. Carcinogenesis 2007;28:2154-9.
25. Lai MT, Chen RH, Tsai FJ, Wan L, Chen WC. Glutathione S-transferase M1 gene but not insulin-like growth factor-2 gene or epidermal growth factor gene is associated with prostate cancer. Urol Oncol 2005;23:225-9.
26. Kim YJ, Yoon JH, Kim CY, et al. IGF2 polymorphisms are associated with hepatitis B virus clearance and hepatocellular carcinoma. Biochem Biophys Res Commun 2006;346:38-44.
27. Stolzenberg-Solomon RZ, Limburg P, Pollak M, Taylor PR, Virtamo J, Albanes D. Insulin-like growth factor (IGF)-1, IGF-binding protein-3, and pancreatic cancer in male smokers. Cancer Epidemiol Biomarkers Prev 2004;13:438-44.
28. Wolpin BM, Michaud DS, Giovannucci EL, et al. Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer 2007;97:98-104.
29. Karna E, Surazynski A, Orlowski K, et al. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer. Int J Exp Pathol 2002;83:239-45.
30. Evans JD, Eggo MC, Donovan IA, Bramhall SR, Neoptolemos JP. Serum levels of insulin-like growth factors (IGF-I and IGF-II) and their binding protein (IGFBP-3) are not elevated in pancreatic cancer. Int J Pancreatol 1997;22:95-100.
31. Hassan MM, Wolff RA, Bondy ML, et al. Risk factors for pancreatic cancer: synergy of smoking with family history of pancreatic cancer and diabetes mellitus. Am J Gastr 2007;102:2696-707.
32. Livak KJ. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 1999;14:143-9.
33. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995;310:170.
34. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004;96:434-42.
35. Li D, Hassan MM. Letter of response to comments on the article entitled Passive smoking and use of noncigarette tobacco products and risk for pancreatic cancer: case-control study. Cancer 2008;112:672.
36. Wang F, Herrington M, Larsson J, et al. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003;2:4.
37. Permert J, Ihse I, Jorfeldt L, et al. Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg 1993;159:101-7.
38. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 1995;273:1605-9.
39. Huxley R, Ansary-Moghaddam A, Berrington de González A, Barzi F, Woodward M. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83.
40. Mazumder B, Seshadri V, Fox PL. Translational control by the 3′-UTR: the ends specify the means. Trends Biochem Sci 2003;28:91-8.
41. Diorio C, Brisson J, Berube S, Pollak M. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 2008;17:880-8.
42. Sandovici I, Leppert M, Hawk PR, Suarez A, Linares Y, Sapienza C. Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. Hum Mol Genet 2003;12:1569-78.
43. Sakatani T, Wei M, Katoh M, et al. Epigenetic heterogeneity at imprinted loci in normal populations. Biochem Biophys Res Commun 2001;283:1124-30.
44. Savage SA, Woodson K, Walk E, et al. National Osteosarcoma Etiology Study Group. Analysis of genes critical for growth regulation identifies insulin-like growth factor 2 receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol Biomarkers Prev 2007;16:1667-74.
45. Gaunt TR, Cooper JA, Miller GJ, Day IN, O'Dell SD. Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet 2001;10:1491-501.
46. Gomes MV, Soares MR, Pasqualim-Neto A, Marcondes CR, Lôbo RB, Ramos ES. Association between birth weight, body mass index and IGF2/ApaI polymorphism. Growth Horm IGF Res 2005;15:360-2.
47. O'Dell SD, Miller GJ, Cooper JA, et al. ApaI polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord 1997;21:822-5.
48. Heude KK, Ong R, Luben NJ, Wareham, Sandhu MS. Study of association between common variation in the insulin-like growth factor 2 gene and indices of obesity and body size in middle-aged men and women. J Clin Endocrinol Metab 2007;92:2734-8.